J2151 HCPCS Level II code: Injection, mannitol, 250 mg
J2151 is the HCPCS code for “Injection, mannitol, 250 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2151Injection, mannitol, 250 mg
Short description: Inj, mannitol, 250 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2151 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2025
Where J2151 sits
- 1J codesDrugs administered other than orally
- 2Active code J2151Injection, mannitol, 250 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2151 mean?
J2151 is the HCPCS code for “Injection, mannitol, 250 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2151?
CMS lists J2151’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2151
All J codesJ2010Injection, lincomycin hcl, up to 300 mgJ2020Injection, linezolid, 200 mgJ2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mgJ2060Injection, lorazepam, 2 mgJ2062Loxapine for inhalation, 1 mgJ2150Injection, mannitol, 25% in 50 mlJ2170Injection, mecasermin, 1 mgJ2175Injection, meperidine hydrochloride, per 100 mgJ2180Injection, meperidine and promethazine hcl, up to 50 mgJ2182Injection, mepolizumab, 1 mgJ2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mgJ2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg